175 results on '"Salomone, Fabrizio"'
Search Results
2. Efficacy of synthetic surfactant (CHF5633) bolus and/or lavage in meconium-induced lung injury in ventilated newborn rabbits
- Author
-
Xu, Yaling, Guo, Xiaojing, Chen, Meimei, Ricci, Francesca, Salomone, Fabrizio, Murgia, Xabier, and Sun, Bo
- Published
- 2023
- Full Text
- View/download PDF
3. Surfactant lung delivery with LISA and InSurE in adult rabbits with respiratory distress
- Author
-
Ricci, Francesca, Bresesti, Ilia, LaVerde, Paola Azzurra Maria, Salomone, Fabrizio, Casiraghi, Costanza, Mersanne, Arianna, Storti, Matteo, Catozzi, Chiara, Tigli, Laura, Zecchi, Riccardo, Franceschi, Pietro, Murgia, Xabier, Simonato, Manuela, Cogo, Paola, Carnielli, Virgilio, and Lista, Gianluca
- Published
- 2021
- Full Text
- View/download PDF
4. Budesonide with surfactant decreases systemic responses in mechanically ventilated preterm lambs exposed to fetal intra-amniotic lipopolysaccharide
- Author
-
Hillman, Noah H., Kemp, Matthew W., Fee, Erin, Rittenschober-Böhm, Judith, Royse, Emily, Abugisisa, Leenah, Salomone, Fabrizio, Musk, Gabrielle C., and Jobe, Alan H.
- Published
- 2021
- Full Text
- View/download PDF
5. Sample preparation strategy for the detection of steroid-like compounds using MALDI mass spectrometry imaging: pulmonary distribution of budesonide as a case study
- Author
-
Zecchi, Riccardo, Franceschi, Pietro, Tigli, Laura, Amidani, Davide, Catozzi, Chiara, Ricci, Francesca, Salomone, Fabrizio, Pieraccini, Giuseppe, Pioselli, Barbara, and Mileo, Valentina
- Published
- 2021
- Full Text
- View/download PDF
6. Dose of budesonide with surfactant affects lung and systemic inflammation after normal and injurious ventilation in preterm lambs
- Author
-
Hillman, Noah H., Abugisisa, Leenah, Royse, Emily, Fee, Erin, Kemp, Matthew W., Kramer, Boris W., Schmidt, Augusto F., Salomone, Fabrizio, Clarke, Michael W., Musk, Gabrielle C., and Jobe, Alan H.
- Published
- 2020
- Full Text
- View/download PDF
7. Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned
- Author
-
Bianco, Federico, Salomone, Fabrizio, Milesi, Ilaria, Murgia, Xabier, Bonelli, Sauro, Pasini, Elena, Dellacà, Raffaele, Ventura, Maria Luisa, and Pillow, Jane
- Published
- 2021
- Full Text
- View/download PDF
8. Behavior of thin liquid films from aqueous solutions of a pulmonary surfactant in presence of corticosteroids
- Author
-
Todorov, Roumen, Exerowa, Dotchi, Alexandrova, Lidia, Platikanov, Dimo, Terziyski, Ivan, Nedyalkov, Michail, Pelizzi, Nicola, and Salomone, Fabrizio
- Published
- 2017
- Full Text
- View/download PDF
9. Thin liquid films from a new synthetic pulmonary surfactant preparation
- Author
-
Todorov, Roumen, Exerowa, Dotchi, Alexandrova, Lidia, Platikanov, Dimo, Nedyalkov, Michail, Bianco, Federico, Razzetti, Roberta, Salomone, Fabrizio, and Pelizzi, Nicola
- Published
- 2017
- Full Text
- View/download PDF
10. Dose-Response Study on Surfactant Nebulization Therapy During Nasal Continuous Positive Airway Pressure Ventilation in Spontaneously Breathing Surfactant-Deficient Newborn Piglets*
- Author
-
Rey-Santano, Carmen, Mielgo, Victoria, Gomez-Solaetxe, Miguel Angel, Ricci, Francesca, Bianco, Federico, Salomone, Fabrizio, and Loureiro, Begoña
- Published
- 2020
- Full Text
- View/download PDF
11. Non-invasive ventilation and surfactant treatment as the primary mode of respiratory support in surfactant-deficient newborn piglets
- Author
-
Rey-Santano, Carmen, Mielgo, Victoria E, Gomez-Solaetxe, Miguel Angel, Ricci, Francesca, Bianco, Federico, Salomone, Fabrizio, Loureiro, Begoña, and de Heredia y Goya, Jon López
- Published
- 2018
- Full Text
- View/download PDF
12. Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs
- Author
-
Zecchi, Riccardo, Franceschi, Pietro, Tigli, Laura, Ricci, Francesca, Boscaro, Francesca, Pioselli, Barbara, Mileo, Valentina, Murgia, Xabier, Bianco, Federico, Salomone, Fabrizio, Schmidt, Augusto F., Hillman, Noah H., Kemp, Matthew W., and Jobe, Alan H.
- Published
- 2019
- Full Text
- View/download PDF
13. Tracing exogenous surfactant in vivo in rabbits by the natural variation of 13C
- Author
-
Giambelluca, Sonia, Ricci, Francesca, Simonato, Manuela, Vedovelli, Luca, Traldi, Umberto, Correani, Alessio, Casiraghi, Costanza, Storti, Matteo, Mersanne, Arianna, Cogo, Paola, Salomone, Fabrizio, and Carnielli, Virgilio P.
- Published
- 2019
- Full Text
- View/download PDF
14. Metal ions affect insulin-degrading enzyme activity
- Author
-
Grasso, Giuseppe, Salomone, Fabrizio, Tundo, Grazia R., Pappalardo, Giuseppe, Ciaccio, Chiara, Spoto, Giuseppe, Pietropaolo, Adriana, Coletta, Massimo, and Rizzarelli, Enrico
- Published
- 2012
- Full Text
- View/download PDF
15. A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape
- Author
-
Salomone, Fabrizio, Cardarelli, Francesco, Di Luca, Mariagrazia, Boccardi, Claudia, Nifosì, Riccardo, Bardi, Giuseppe, Di Bari, Lorenzo, Serresi, Michela, and Beltram, Fabio
- Published
- 2012
- Full Text
- View/download PDF
16. Structural and haemodynamic evaluation of less invasive surfactant administration during nasal intermittent positive pressure ventilation in surfactant-deficient newborn piglets.
- Author
-
Mielgo, Victoria, Gastiasoro, Elena, Salomone, Fabrizio, Ricci, Francesca, Gomez-Solaetxe, Miguel A., Olazar, Lara, Loureiro, Begoña, and Rey-Santano, Carmen
- Subjects
POSITIVE pressure ventilation ,INTRANASAL administration ,PIGLETS ,VASCULAR catheters ,RESPIRATORY distress syndrome ,LUNGS ,NEAR infrared spectroscopy - Abstract
The most recent approaches to the initial treatment of respiratory distress syndrome (RDS)- involve non-invasive ventilation (NIV) and less-invasive surfactant (SF) administration (LISA). Combining these techniques has been proven a useful treatment option for SF-deficient neonates. The objective of this study was to explore the impact on the brain (using cerebral near infrared spectroscopy, NIRS) of different LISA methods during NIV, using nasal intermittent positive pressure ventilation (NIPPV) for treating neonatal RDS. For this, we used five groups of spontaneously breathing newborn piglets (n = 6/group) with bronchoalveolar lavage (BAL)-induced respiratory distress which received NIPPV only (controls), poractant-alfa using the INSURE-like method (bolus delivery) followed by NIPPV, or poractant-alfa using one of three LISA devices, 1) a nasogastric tube (NT), 2) a vascular catheter (VC) or 3) the LISAcath® catheter. We assessed pulmonary, hemodynamic and cerebral effects, and performed histological analysis of lung and brain tissue. Following BALs, the piglets developed severe RDS (pH<7.2, P
aCO2 >70 mmHg, PaO2 <70 mmHg, dynamic compliance<0.5 ml/cmH2 O/kg at FiO2 = 1). Poractant-alfa administration using different LISA techniques during NIPPV was well tolerated and efficacious in newborn piglets. In our study, although all groups showed normal physiological ranges of total lung injury score and biochemical lung analysis, VC and LISAcath® catheters were associated with better values of lung compliance and lower values of lung damage than NIPPV, NT or INSURE-like methods. Moreover, neither of the SF administration methods used (LISA or INSURE-like) had a significant impact on the histological neonatal brain injury score. Of note, the LISAcath® has been recently withdrawn from the market. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
17. Beyond the Interface: Improved Pulmonary Surfactant-Assisted Drug Delivery through Surface-Associated Structures.
- Author
-
García-Mouton, Cristina, Echaide, Mercedes, Serrano, Luis A., Orellana, Guillermo, Salomone, Fabrizio, Ricci, Francesca, Pioselli, Barbara, Amidani, Davide, Cruz, Antonio, and Pérez-Gil, Jesús
- Subjects
PULMONARY surfactant ,DRUG carriers ,FLUORESCENT dyes ,INTERFACE structures ,NANOCARRIERS ,BUDESONIDE ,DIPYRRINS - Abstract
Pulmonary surfactant (PS) has been proposed as an efficient drug delivery vehicle for inhaled therapies. Its ability to adsorb and spread interfacially and transport different drugs associated with it has been studied mainly by different surface balance designs, typically interconnecting various compartments by interfacial paper bridges, mimicking in vitro the respiratory air–liquid interface. It has been demonstrated that only a monomolecular surface layer of PS/drug is able to cross this bridge. However, surfactant films are typically organized as multi-layered structures associated with the interface. The aim of this work was to explore the contribution of surface-associated structures to the spreading of PS and the transport of drugs. We have designed a novel vehiculization balance in which donor and recipient compartments are connected by a whole three-dimensional layer of liquid and not only by an interfacial bridge. By combining different surfactant formulations and liposomes with a fluorescent lipid dye and a model hydrophobic drug, budesonide (BUD), we observed that the use of the bridge significantly reduced the transfer of lipids and drug through the air–liquid interface in comparison to what can be spread through a fully open interfacial liquid layer. We conclude that three-dimensional structures connected to the surfactant interfacial film can provide an important additional contribution to interfacial delivery, as they are able to transport significant amounts of lipids and drugs during surfactant spreading. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. A novel deuterium‐based model for measurement of exogenous surfactant using deuterium‐depleted water.
- Author
-
Simonato, Manuela, Ricci, Francesca, Catozzi, Chiara, Storti, Matteo, Correani, Alessio, Salomone, Fabrizio, Cogo, Paola, and Carnielli, Virgilio P.
- Published
- 2022
- Full Text
- View/download PDF
19. Nebulization of High-Dose Poractant Alfa in Newborn Piglets on Nasal Continuous Positive Airway Pressure Yields Therapeutic Lung Doses of Phospholipids.
- Author
-
Nord, Anders, Bianco, Federico, Salomone, Fabrizio, Ricci, Francesca, Schlun, Martin, Linner, Rikard, and Cunha-Goncalves, Doris
- Subjects
PULMONARY surfactant ,CONTINUOUS positive airway pressure ,LUNG diseases ,TECHNETIUM ,SWINE ,SYNTHETIC drugs ,RADIONUCLIDE imaging ,DESCRIPTIVE statistics ,PHOSPHOLIPIDS ,HEMODYNAMICS ,ANIMALS - Abstract
Objective It is not known how much surfactant must be nebulized to reach a lung dose of phospholipids equivalent to that obtained by the instillation of 200 mg/kg of surfactant. We aimed to assess the feasibility of nebulizing a high-dose of poractant alfa with the eFlow-Neos investigational vibrating-membrane nebulizer in newborn piglets on nasal continuous positive airway pressure (nCPAP) and to determine whether this intervention would yield therapeutic lung doses of phospholipids. Study Design Twelve 1-day-old piglets on nCPAP received 600 mg/kg of poractant alfa admixed with technetium-99m via nebulization. Six piglets receiving 200 mg/kg of instilled synthetic surfactant served as controls. Lung deposition (percentage of the nominal dose) was determined by gamma scintigraphy, and the phospholipids' lung dose was calculated. Results The lung dose of phospholipids (mean ± standard deviation [SD]) was 138 ± 96 mg/kg with nebulization, and 172 ± 24 mg/kg with instillation (p = 0.42). Nebulization took 58 ± 12 minutes. The arterial partial pressure of carbon dioxide increased from 6.7 ± 1.1 to 7.2 ± 1.1 kPa during nebulization (p = 0.04). Cerebral oximetry remained stable, and there was no hemodynamic instability. Conclusion Nebulization was well tolerated, and the mean lung dose of phospholipids was above 100 mg/kg, that is, not different from the instillation group. These experimental findings suggest that it may be feasible to reach therapeutic lung doses of phospholipids by surfactant nebulization during nCPAP. Key Points It is not known if effective lung doses of surfactant can be delivered by nebulization. Nebulization of high-dose surfactant in newborn piglets on nCPAP was well tolerated. A high-dose of nebulized poractant alfa yielded therapeutic lung doses of phospholipids. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Daily Intraperitoneal Administration of Rosiglitazone Does Not Improve Lung Function or Alveolarization in Preterm Rabbits Exposed to Hyperoxia.
- Author
-
Aquila, Giorgio, Regin, Yannick, Murgia, Xabier, Salomone, Fabrizio, Casiraghi, Costanza, Catozzi, Chiara, Scalera, Enrica, Storti, Matteo, Stretti, Francesca, Aquino, Giancarlo, Cavatorta, Giorgia, Volta, Roberta, Di Pasquale, Carmelina, Amato, Caterina, Bignami, Fabio, Amidani, Davide, Pioselli, Barbara, Sgarbi, Elisa, Ronchi, Paolo, and Mazzola, Giuseppe
- Subjects
LUNGS ,HYPEROXIA ,BRONCHOPULMONARY dysplasia ,ROSIGLITAZONE ,RABBITS ,BLOOD lipids - Abstract
Thiazolidinediones (TZDs) are potent PPARγ agonists that have been shown to attenuate alveolar simplification after prolonged hyperoxia in term rodent models of bronchopulmonary dysplasia. However, the pulmonary outcomes of postnatal TZDs have not been investigated in preterm animal models. Here, we first investigated the PPARγ selectivity, epithelial permeability, and lung tissue binding of three types of TZDs in vitro (rosiglitazone (RGZ), pioglitazone, and DRF-2546), followed by an in vivo study in preterm rabbits exposed to hyperoxia (95% oxygen) to investigate the pharmacokinetics and the pulmonary outcomes of daily RGZ administration. In addition, blood lipids and a comparative lung proteomics analysis were also performed on Day 7. All TZDs showed high epithelial permeability through Caco-2 monolayers and high plasma and lung tissue binding; however, RGZ showed the highest affinity for PPARγ. The pharmacokinetic profiling of RGZ (1 mg/kg) revealed an equivalent biodistribution after either intratracheal or intraperitoneal administration, with detectable levels in lungs and plasma after 24 h. However, daily RGZ doses of 1 mg/kg did not improve lung function in preterm rabbits exposed to hyperoxia, and daily 10 mg/kg doses were even associated with a significant lung function worsening, which could be partially explained by the upregulation of lung inflammation and lipid metabolism pathways revealed by the proteomic analysis. Notably, daily postnatal RGZ produced an aberrant modulation of serum lipids, particularly in rabbit pups treated with the 10 mg/kg dose. In conclusion, daily postnatal RGZ did not improve lung function and caused dyslipidemia in preterm rabbits exposed to hyperoxia. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. Preclinical Assessment of Nebulized Surfactant Delivered through Neonatal High Flow Nasal Cannula Respiratory Support.
- Author
-
Ricci, Francesca, Mersanne, Arianna, Storti, Matteo, Nutini, Marcello, Pellicelli, Giulia, Carini, Angelo, Milesi, Ilaria, Lombardini, Marta, Dellacà, Raffaele L., Thomson, Merran A., Murgia, Xabier, Lavizzari, Anna, Bianco, Federico, and Salomone, Fabrizio
- Subjects
NASAL cannula ,LUNGS ,NEONATAL intensive care units ,SURFACE active agents ,RESPIRATORY distress syndrome ,PREMATURE infants ,PULMONARY surfactant - Abstract
High-flow nasal cannula (HFNC) is a non-invasive respiratory support (NRS) modality to treat premature infants with respiratory distress syndrome (RDS). The delivery of nebulized surfactant during NRS would represent a truly non-invasive method of surfactant administration and could reduce NRS failure rates. However, the delivery efficiency of nebulized surfactant during HFNC has not been evaluated in vitro or in animal models of respiratory distress. We, therefore, performed first a benchmark study to compare the surfactant lung dose delivered by commercially available neonatal nasal cannulas (NCs) and HFNC circuits commonly used in neonatal intensive care units. Then, the pulmonary effect of nebulized surfactant delivered via HFNC was investigated in spontaneously breathing rabbits with induced respiratory distress. The benchmark study revealed the surfactant lung dose to be relatively low for both types of NCs tested (Westmed NCs 0.5 ± 0.45%; Fisher & Paykel NCs 1.8 ± 1.9% of a nominal dose of 200 mg/kg of Poractant alfa). The modest lung doses achieved in the benchmark study are compatible with the lack of the effect of nebulized surfactant in vivo (400 mg/kg), where arterial oxygenation and lung mechanics did not improve and were significantly worse than the intratracheal instillation of surfactant. The results from the present study indicate a relatively low lung surfactant dose and negligible effect on pulmonary function in terms of arterial oxygenation and lung mechanics. This negligible effect can, for the greater part, be explained by the high impaction of aerosol particles in the ventilation circuit and upper airways due to the high air flows used during HFNC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. Deuterium‐depleted water: A new tracer to label pulmonary surfactant lipids in adult rabbits.
- Author
-
Simonato, Manuela, Ricci, Francesca, Catozzi, Chiara, Storti, Matteo, Giambelluca, Sonia, Correani, Alessio, Salomone, Fabrizio, Cogo, Paola, and Carnielli, Virgilio
- Subjects
PULMONARY surfactant ,RABBITS ,DRINKING water ,PALMITIC acid ,MASS spectrometry - Abstract
Stable isotope tracing can be safely used for metabolic studies in animals and humans. The endogenous biosynthesis of lipids (lipogenesis) is a key process throughout the entire life but especially during brain and lung growth. Adequate synthesis of pulmonary surfactant lipids is indispensable for life. With this study, we report the use of deuterium‐depleted water (DDW), suitable for human consumption, as metabolic precursor for lipogenesis. We studied 13 adult rabbits for 5 days. Four rabbits drank tap water (TW) and served as controls; in four animals, DDW was substituted to drinking water, whereas five drank deuterium‐enriched water (DEW). After 5 days, a blood sample and a bronchoalveolar lavage (BAL) sample were collected. The 2H/1H (δ2H) of BAL palmitic acid (PA) desaturated phosphatidylcholine (DSPC), the major phospholipid of pulmonary surfactant, and of plasma water was determined by high‐resolution mass spectrometry. We found that the δ2H values of DDW, DEW and TW were −984 ± 2‰, +757 ± 2‰ and −58 ± 1‰, respectively. After 5 days, plasma water values were −467 ± 87‰, +377 ± 56‰ and −53 ± 6‰, and BAL DSPC‐PA was −401 ± 27‰, −96 ± 38‰ and −249 ± 9‰ in the DDW, DEW and TW, respectively. With this preliminary study, we demonstrated the feasibility of using DDW to label pulmonary surfactant lipids. This novel approach can be used in animals and in humans, and we speculate that it could be associated with more favourable study compliance than DEW in human studies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. A new anesthesia protocol enabling longitudinal lung-function measurements in neonatal rabbits by micro-CT.
- Author
-
Ferrini, Erica, Leo, Ludovica, Corsi, Luisa, Catozzi, Chiara, Salomone, Fabrizio, Ragionieri, Luisa, Pennati, Francesca, and Stellari, Franco Fabio
- Subjects
LUNGS ,RESPIRATORY mechanics ,RABBITS ,RESPIRATORY organs ,COMPUTED tomography ,ANESTHESIA ,LUNG diseases - Abstract
Micro-computed tomography (micro-CT) imaging is an emerging technology with many applications in small animals, for example, the study of pulmonary diseases, although clear guidelines and critical mass of evidence are still missing in the preclinical literature. The neonatal rabbit is a valuable model for studying pulmonary development. However, the longitudinal monitoring of lung function by micro-CT can be challenging. Distinctive datasets corresponding to the end-inspiration and end-expiration phases need to be generated and analyzed to derive lung-functional parameters. The quality of CT scans and the reliability of parameters obtained remain highly dependent on the anesthesia protocol used. Three different anesthetic protocols were tested. The combination of dexmedetomidine 0.25 mg/kg injected intraperitoneally followed by 1% isoflurane was found to facilitate CT imaging at 4 and 11 days after birth. Contrarily, isoflurane and ketamine-xylazine were found unsuitable and thus not investigated further. Total lung volumes significantly increased at day 11 compared with baseline in both respiratory phases, whereas lung tissue remained constant. As expected, functional residual capacity, air-to-tissue ratio, and minute ventilation were significantly increased at day 11 in each animal. Those parameters were correlated with inspiratory capacity, compliance, elastance, and resistance of both respiratory system and tissue component, as measured by flexiVent. Lung development was also evaluated by histomorphometric analyses. In conclusion, we have identified a safe and suitable anesthesia protocol for micro-CT imaging in neonatal rabbits. Moreover, the possibility to longitudinally measure lung function in the same subject dramatically reduced the intraexperimental variability. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Design-Based Stereology of the Lung in the Hyperoxic Preterm Rabbit Model of Bronchopulmonary Dysplasia.
- Author
-
Mühlfeld, Christian, Schulte, Henri, Jansing, Johanna Christine, Casiraghi, Costanza, Ricci, Francesca, Catozzi, Chiara, Ochs, Matthias, Salomone, Fabrizio, and Brandenberger, Christina
- Published
- 2021
- Full Text
- View/download PDF
25. Lung ultrasound features and relationships with respiratory mechanics of evolving BPD in preterm rabbits and human neonates.
- Author
-
Loi, Barbara, Casiraghi, Costanza, Catozzi, Chiara, Storti, Matteo, Lucattelli, Monica, Bartalesi, Barbara, Yousef, Nadya, Salomone, Fabrizio, and De Luca, Daniele
- Subjects
ULTRASONIC imaging ,RESPIRATORY mechanics ,NEWBORN infants ,RABBITS ,LUNGS - Abstract
Evolving bronchopulmonary dysplasia (BPD) is characterized by impaired alveolarization leading to lung aeration inhomogeneities. Hyperoxia-exposed preterm rabbits have been proposed to mimic evolving BPD; therefore, we aimed to verify if this model has the same lung ultrasound and mechanical features of evolving BPD in human neonates. Semiquantitative lung ultrasound and lung mechanics measurement was performed in 25 preterm rabbits (28 days of gestation) and 25 neonates (mean gestational age = 26wk) with evolving BPD. A modified rabbit lung ultrasound score (rLUS) and a validated neonatal lung ultrasound score (LUS) were used. Lung ultrasound images were recorded and evaluated by two independent observers blinded to each other's evaluation. Lung ultrasound findings were equally heterogeneous both in rabbits as in human neonates and encompassed all the classical lung ultrasound semiology. Lung ultrasound and histology examination were also performed in 13 term rabbits kept under normoxia as further control and showed the absence of ultrasound and histology abnormalities compared with hyperoxia-exposed preterm rabbits. The interrater absolute agreement for the evaluation of lung ultrasound images in rabbits was very high [ICC: 0.989 (95%CI: 0.975-0.995); P < 0.0001], and there was no difference between the two observers. Lung mechanics parameters were similarly altered in both rabbits and human neonates. There were moderately significant correlations between airway resistances and lung ultrasound scores in rabbits (r = 0.519; P = 0.008) and in neonates (r = 0.409; P = 0.042). In conclusion, the preterm rabbit model fairly reproduces the lung ultrasound and mechanical characteristics of preterm neonates with evolving BPD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
26. Surfactant nebulization therapy during NIPPV ventilation in surfactant‐deficient newborn piglets.
- Author
-
Rey‐Santano, Carmen, Mielgo, Victoria, Gastiasoro, Elena, Bianco, Federico, Salomone, Fabrizio, and Gomez‐Solaetxe, Miguel Angel
- Published
- 2021
- Full Text
- View/download PDF
27. Intratracheal budesonide/surfactant attenuates hyperoxia-induced lung injury in preterm rabbits.
- Author
-
Gie, Andre G., Regin, Yannick, Salaets, Thomas, Casiraghi, Costanza, Salomone, Fabrizio, Deprest, Jan, Vanoirbeek, Jeroen, and Toelen, Jaan
- Abstract
Recent clinical trials have shown improvements in neonatal outcomes after intratracheal administration of a combination of budesonide/surfactant (ITBS) in infants at risk of bronchopulmonary dysplasia. However, the effect of ITBS on lung function and alveolar structure is not known. We aimed to determine the effect of ITBS on lung function, parenchymal structure, and inflammatory cytokine expression in a relevant preterm animal model for bronchopulmonary dysplasia. Premature neonatal rabbits were administered a single dose of ITBS on the day of delivery and exposed to 95% oxygen. Following 7 days of hyperoxia, in vivo forced oscillation and pressure-volume maneuvers were performed to examine pulmonary function. Histological and molecular analysis was performed to assess alveolar and extracellular matrix (ECM) morphology, along with gene expression of connective tissue growth factor (CTGF), IL-8, and CCL-2. ITBS attenuated the functional effect of hyperoxia-induced lung injury and limited the change to respiratory system impedance, measured using the forced oscillation technique. Treatment effects were most obvious in the small airways, with significant effects on small airway resistance and small airway reactance. In addition, ITBS mitigated the decrease in inspiratory capacity and static compliance. ITBS restricted alveolar septal thickening without altering the mean linear intercept and mitigated hyperoxia-induced remodeling of the ECM. These structural changes were associated with improved inspiratory capacity and lung compliance. Gene expression of CTGF, IL-8, and CCL-2 was significantly downregulated in the lung. Treatment with ITBS shortly after delivery attenuated the functional and structural consequences of hyperoxia-induced lung injury to day 7 of life in the preterm rabbit. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
28. Addressing the drug-delivery endosomalentrapment issue through a CPP-AMP chimeric peptide
- Author
-
SALOMONE, FABRIZIO, Salomone, Fabrizio, and BELTRAM, Fabio
- Subjects
Settore BIO/11 - Biologia Molecolare ,Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin) - Published
- 2015
29. Surfactant Injury in the Early Phase of Severe Meconium Aspiration Syndrome.
- Author
-
Autilio, Chiara, Echaide, Mercedes, Shankar-Aguilera, Shivani, Bragado, Rafael, Amidani, Davide, Salomone, Fabrizio, Pérez-Gil, Jesüs, and De Luca, Daniele
- Subjects
ADULT respiratory distress syndrome ,MECONIUM aspiration syndrome ,PULMONARY surfactant ,NANOSTRUCTURES ,COHORT analysis - Abstract
No in vivo data are available regarding the effect of meconium on human surfactant in the early stages of severe meconium aspiration syndrome (MAS). In the present study, we sought to characterize the changes in surfactant composition, function, and structure during the early phase of meconium injury. We designed a translational prospective cohort study of nonbronchoscopic BAL of neonates with severe MAS (n = 14) or no lung disease (n = 18). Surfactant lipids were analyzed by liquid chromatography-high-resolution mass spectrometry. Secretory phospholipase A
2 subtypes IB, V, and X and SP-A (surfactant protein A) were assayed by ELISA. SP-B and SP-C were analyzed by Western blotting under both nonreducing and reducing conditions. Surfactant function was assessed by adsorption test and captive bubble surfactometry, and lung aerationwas evaluated by semiquantitative lung ultrasound. Surfactant nanostructure was studied using cryo-EM and atomic force microscopy. Several changes in phospholipid subclasses were detected during MAS. Lysophosphatidylcholine species released by phospholipase A2 hydrolysis were increased. SP-B and SP-C were significantly increased together with some shorter immature forms of SP-B. Surfactant function was impaired and correlated with poor lung aeration. Surfactant nanostructure was significantly damaged in terms of vesicle size, tridimensional complexity, and compactness. Various alterations of surfactant phospholipids and proteins were detected in the early phase of severe meconium aspiration and were due to hydrolysis and inflammation and a defensive response. This impairs both surfactant structure andfunction, finally resulting in reduced lung aeration. These findings support the development of new surfactant protection and antiinflammatory strategies for severeMAS. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
30. Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.
- Author
-
Rey-Santano, Carmen, Mielgo, Victoria E., Gomez-Solaetxe, Miguel Angel, Bianco, Federico, Salomone, Fabrizio, and Loureiro, Begoña
- Published
- 2020
- Full Text
- View/download PDF
31. Impact of Body Position on Lung Deposition of Nebulized Surfactant in Newborn Piglets on Nasal Continuous Positive Airway Pressure.
- Author
-
Cunha-Goncalves, Doris, Nord, Anders, Bianco, Federico, Salomone, Fabrizio, Ricci, Francesca, Schlun, Martin, Linner, Rikard, and Perez-de-Sa, Valeria
- Subjects
CONTINUOUS positive airway pressure ,POSTURE ,SURFACE active agents ,PIGLETS ,LUNGS - Abstract
Introduction: The ideal body position during surfactant nebulization is not known. Objective: The aim of this study was to determine whether body positioning during surfactant nebulization influences surfactant distribution and deposition in the lungs. Methods: Twenty-four 12- to 36-h-old full-termpiglets (1.3–2.2 kg) on nasal continuous positive airway pressure (nCPAP) were randomized into four groups: lateral decubitus with right or left side up, prone or supine positions (n = 6 each). All animals received 200 mg kg
–1 of poractant alfa mixed with 200 MBq of99m technetium-nanocolloid via a customized eFlow-Neos investigational vibrating-membrane nebulizer. Surfactant deposition (percentage of the administered dose) was measured by gamma scintigraphy. Results: Comparing all groups, the mean total lung surfactant deposition was significantly higher in the prone position (32.4 ± 7.7%, p = 0.03). The deposition in this group was higher in the right lung (21.0 ± 8.6 vs. 11.3 ± 5.7%, p = 0.04). When nebulization was performed in the lateral decubitus, most of the surfactant was found in the dependent lung, regardless of which side the piglet lay on (right side up 15.3 ± 1.0 vs. 3.4 ± 1.0%, p = 0.06, and left side up 11.2 ± 9.8 vs. 1.8 ± 0.7%, p = 0.04). Conclusions: In spontaneously breathing animals on nCPAP, the prone position yielded the highest lung dose. Higher deposition rates in the dependent lung while on lateral decubitus indicates that deposition was also influenced by gravity. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
32. Small Molecule Inhibitor Adjuvant Surfactant Therapy Attenuates Ventilator- and Hyperoxia-Induced Lung Injury in Preterm Rabbits.
- Author
-
Das, Pragnya, Curstedt, Tore, Agarwal, Beamon, Prahaladan, Varsha M., Ramirez, John, Bhandari, Shreya, Syed, Mansoor A., Salomone, Fabrizio, Casiraghi, Costanza, Pelizzi, Nicola, and Bhandari, Vineet
- Subjects
SMALL molecules ,LUNG injuries ,SURFACE active agents ,RABBITS ,PREMATURE infants - Abstract
Background: Invasive mechanical ventilation (IMV) has become one of the mainstays of therapy in NICUs worldwide, as a result of which premature babies with extremely low birth weight have been able to survive. Although lifesaving, IMV can result in lung inflammation and injury. Surfactant therapy is considered a standard of care in preterm infants with immature lungs. Recently, small molecule inhibitors like siRNAs and miRNAs have been used for therapeutic purposes. Ddit3 (CHOP), Ang2 and miR34a are known to be upregulated in experimental lung injury. We wanted to test whether inhibitors for these molecules (CHOP siRNA, Ang2 siRNA, and miR34a antagomir) if used alone or with a combination with surfactant (Curosurf
® ) would help in reducing ventilation and hyperoxia-induced injury in an experimental lung injury model. Methods: Preterm rabbits born by cesarean section were intratracheally instilled with the three small molecule inhibitors with or without Curosurf® prior to IMV and hyperoxia exposure. Prior to testing the inhibitors in rabbits, these small molecule inhibitors were transfected in mouse lung epithelial cells (MLE12 and AECII) and delivered to neonatal mouse pups intranasally as a proof of concept that surfactant (Curosurf® ) could be used as an effective vehicle for administration of such drugs. Survival, pulmonary function tests, histopathology, immunostaining, quantitative PCR and western blotting were done to see the adjuvant effect of surfactant with these three small molecule inhibitors. Results: Our data shows that Curosurf® can facilitate transfection of small molecules in MLE12 cells with the same and/or increased efficiency as Lipofectamine. Surfactant given alone or as an adjuvant with small molecule inhibitors increases survival, decreases IMV and hyperoxia-induced inflammation, improves pulmonary function and lung injury scores in preterm rabbit kits. Conclusion: Our study shows that Curosurf® can be used successfully as an adjuvant therapy with small molecule inhibitors for CHOP/Ang2/miR34a. In this study, of the three inhibitors used, miR34a inhibitor seemed to be the most promising compound to combat IMV and hyperoxia-induced lung injury in preterm rabbits. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
33. In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.
- Author
-
Guo, Xiaojing, Luo, Siwei, Amidani, Davide, Rivetti, Claudio, Pieraccini, Giuseppe, Pioselli, Barbara, Catinella, Silvia, Murgia, Xabi, Salomone, Fabrizio, Xu, Yaling, Dong, Ying, and Sun, Bo
- Subjects
RESPIRATORY distress syndrome ,ATOMIC force microscopy ,BASEBALL injuries - Abstract
Poractant alfa and Calsurf are two natural surfactants widely used in China for the treatment of neonatal respiratory distress syndrome, which are extracted from porcine and calf lungs, respectively. The purpose of this experimental study was to compare their in vitro characteristics and in vivo effects in the improvement of pulmonary function and protection of lung injury. The biophysical properties, ultrastructure, and lipid composition of both surfactant preparations were respectively analysed in vitro by means of Langmuir-Blodgett trough (LBT), atomic force microscopy (AFM), and liquid-chromatography mass-spectrometry (LC-MS). Then, as core pharmacological activity, both head-to-head (100 and 200 mg/kg for both surfactants) and licensed dose comparisons (70 mg/kg Calsurf vs. 200 mg/kg Poractant alfa) between the two surfactants were conducted as prophylaxis in preterm rabbits with primary surfactant deficiency, assessing survival time and rate and dynamic compliance of the respiratory system (C
dyn ). Intrapulmonary surfactant pools, morphometric volume density as alveolar expansion (Vv ), and lung injury scores were determined post mortem. AFM and LC-MS analysis revealed qualitative differences in the ultrastructure as well as in the lipid composition of both preparations. Calsurf showed a longer plateau region of the LBT isotherm and lower film compressibility. In vivo, both surfactant preparations improved Cdyn at any dose, although maximum benefits in terms of Vv and intrapulmonary surfactant pools were seen with the 200 mg/kg dose in both surfactants. The group of animals treated with 200 mg/kg of Poractant alfa showed a prolonged survival time and rate compared to untreated but ventilated controls, and significantly ameliorated lung injury compared to Calsurf at any dose, including 200 mg/kg. The overall outcomes suggest the pulmonary effects to be dose dependent for both preparations. The group of animals treated with 200 mg/kg of Poractant alfa showed a significant reduction of mortality. Compared to Calsurf, Poractant alfa exerted better effects if licensed doses were compared, which requires further investigation. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
34. Lung deposition of nebulized surfactant in newborn piglets: Nasal CPAP vs Nasal IPPV.
- Author
-
Nord, Anders, Linner, Rikard, Salomone, Fabrizio, Bianco, Federico, Ricci, Francesca, Murgia, Xabi, Schlun, Martin, Cunha‐Goncalves, Doris, and Perez‐de‐Sa, Valeria
- Published
- 2020
- Full Text
- View/download PDF
35. Surfactant plus budesonide decreases lung and systemic responses to injurious ventilation in preterm sheep.
- Author
-
Hillman, Noah H., Kothe, T. Brett, Schmidt, Augusto F., Kemp, Matthew W., Royse, Emily, Fee, Erin, Salomone, Fabrizio, Clarke, Michael W., Musk, Gabrielle C., and Job, Alan H.
- Subjects
SURFACE active agents ,SHEEP ,LUNGS ,LUNG injuries ,PNEUMONIA ,HYDROXYPROGESTERONE - Abstract
Mechanical ventilation from birth with normal tidal volumes (V
T ) causes lung injury and systemic responses in preterm sheep. The addition of budesonide to surfactant therapy decreases these injury markers. Budesonide and surfactant will decrease the injury from injurious VT ventilation in preterm sheep. Lambs at 126 ± 1 day gestational age were ventilated from birth with either: 1) Normal VT [surfactant 200 mg/kg before ventilation, positive end expiratory pressure (PEEP) 5 cmH2 O, VT 8 mL/kg] or 2) Injury VT (high pressure, 100% oxygen, no PEEP) for 15 min, then further randomized to surfactant + saline or surfactant + 0.25 mg/kg budesonide with Normal VT for 6 h. Lung function and lung, liver, and brain tissues were evaluated for indicators of injury. Injury VT + saline caused significant injury and systemic responses, and Injury VT + budesonide improved lung physiology. Budesonide decreased lung inflammation and decreased pro-inflammatory cytokine mRNA in the lung, liver, and brain to levels similar to Normal VT + saline. Budesonide was present in plasma within 15 min of treatment in both ventilation groups, and less than 5% of the budesonide remained in the lung at 6 h. mRNA sequencing of liver and periventricular white matter demonstrated multiple pathways altered by both Injury VT and budesonide and the combination exposure. In lambs receiving Injury VT , the addition of budesonide to surfactant improved lung physiology and decreased pro-inflammatory cytokine responses in the lung, liver, and brain to levels similar to lambs receiving Normal VT . [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
36. High-yield nontoxic gene transfer through conjugation of the CM₁₈-Tat₁₁ chimeric peptide with nanosecond electric pulses
- Author
-
SALOMONE, FABRIZIO, BELTRAM, Fabio, Breton, Marie, Leray, Isabelle, Cardarelli, Francesco, Boccardi, Claudia, Bonhenry, Daniel, Tarek, Mounir, Mir, Lluis M, Salomone, Fabrizio, Breton, Marie, Leray, Isabelle, Cardarelli, Francesco, Boccardi, Claudia, Bonhenry, Daniel, Tarek, Mounir, Mir, Lluis M, and Beltram, Fabio
- Subjects
technology, industry, and agriculture - Abstract
We report a novel nontoxic, high-yield, gene delivery system based on the synergistic use of nanosecond electric pulses (NPs) and nanomolar doses of the recently introduced CM18-Tat11 chimeric peptide (sequence of KWKLFKKIGAVLKVLTTGYGRKKRRQRRR, residues 1-7 of cecropin-A, 2-12 of melittin, and 47-57 of HIV-1 Tat protein). This combined use makes it possible to drastically reduce the required CM18-Tat11 concentration and confines stable nanopore formation to vesicle membranes followed by DNA release, while no detectable perturbation of the plasma membrane is observed. Two different experimental assays are exploited to quantitatively evaluate the details of NPs and CM18-Tat11 cooperation: (i) cytofluorimetric analysis of the integrity of synthetic 1,2-dioleoyl-sn-glycero-3-phosphocholine giant unilamellar vesicles exposed to CM18-Tat11 and NPs and (ii) the in vitro transfection efficiency of a green fluorescent protein-encoding plasmid conjugated to CM18-Tat11 in the presence of NPs. Data support a model in which NPs induce membrane perturbation in the form of transient pores on all cellular membranes, while the peptide stabilizes membrane defects selectively within endosomes. Interestingly, atomistic molecular dynamics simulations show that the latter activity can be specifically attributed to the CM18 module, while Tat11 remains essential for cargo binding and vector subcellular localization. We argue that this result represents a paradigmatic example that can open the way to other targeted delivery protocols.
- Published
- 2014
37. Surfactant plus budesonide decreases lung and systemic inflammation in mechanically ventilated preterm sheep.
- Author
-
Kothe, T. Brett, Kemp, Matthew W., Schmidt, Augusto, Royse, Emily, Salomone, Fabrizio, Clarke, Michael W., Musk, Gabrielle C., Jobe, Alan H., and Hillman, Noah H.
- Subjects
PNEUMONIA ,DYSPLASIA ,NITRIC-oxide synthases ,LIVER ,SURFACE active agents ,BRONCHOPULMONARY dysplasia ,PREMATURE infants - Abstract
Mechanical ventilation with normal tidal volumes (VT) causes lung and systemic inflammation in preterm sheep. Mechanical ventilation is associated with bronchopulmonary dysplasia (BPD) in preterm infants, and the addition of budesonide to surfactant decreases BPD in clinical trials. Budesonide with surfactant will decrease the lung injury from mechanical ventilation for 24 h in preterm sheep. Lambs at 126 ± 1 day gestational age were delivered and randomized to either: 1) surfactant (200 mg/kg) or 2) surfactant mixed with budesonide (0.25 mg/kg) before mechanical ventilation with VT of 7-8 ml/kg for 2, 6, or 24 h (n = 6 or 7/group). Lung physiology and budesonide levels in the plasma and the lung were measured. Lung tissue, bronchoalveolar lavage fluid (BALF), liver, and brain tissues were evaluated for indicators of injury. High initial budesonide plasma levels of 170 ng/ml decreased to 3 ng/ml at 24 h. Lung tissue budesonide levels were less than 1% of initial dose by 24 h. Although physiological variables were generally similar, budesonide- exposed lambs required lower mean airway pressures, had higher hyperoxia responses, and had more stable blood pressures. Budesonide decreased proinflammatory mRNA in the lung, liver, and brain. Budesonide also decreased total protein and proinflammatory cytokines in BALF, and decreased inducible nitric oxide synthase activation at 24 h. In ventilated preterm lambs, most of the budesonide left the lung within 24 h. The addition of budesonide to surfactant improved physiology, decreased markers of lung injury, and decreased systemic responses in liver and brain. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
38. Cerebral oxygenation associated with INSURE versus LISA procedures in surfactant‐deficient newborn piglet RDS model.
- Author
-
Rey‐Santano, Carmen, Mielgo, Victoria E., Gomez‐Solaetxe, Miguel A., Salomone, Fabrizio, Gastiasoro, Elena, and Loureiro, Begoña
- Published
- 2019
- Full Text
- View/download PDF
39. Local pulmonary drug delivery in the preterm rabbit: feasibility and efficacy of daily intratracheal injections.
- Author
-
Salaets, Thomas, Gie, André, Jimenez, Julio, Aertgeerts, Margo, Gheysens, Olivier, Velde, Greetje Vande, Koole, Michel, Murgia, Xabi, Casiraghi, Costanza, Ricci, Francesca, Salomone, Fabrizio, Villetti, Gino, Allegaert, Karel, Deprest, Jan, and Toelen, Jaan
- Subjects
BRONCHOPULMONARY dysplasia ,RABBITS ,DRUG carriers ,INJECTIONS ,SURFACE active agents ,RADIOACTIVE tracers - Abstract
Recent clinical trials in newborns have successfully used surfactant as a drug carrier for an active compound, to minimize systemic exposure. To investigate the translational potential of surfactant-compound mixtures and other local therapeutics, a relevant animal model is required in which intratracheal administration for maximal local deposition is technically possible and well tolerated. Preterm rabbit pups (born at 28 days of gestation) were exposed to either hyperoxia or normoxia and randomized to receive daily intratracheal surfactant, daily intratracheal saline, or no injections for 7 days. At day 7, the overall lung function and morphology were assessed. Efficacy in terms of distribution was assessed by micro- PET-CT on both day 0 and day 7. Lung function as well as parenchymal and vascular structure were altered by hyperoxia, thereby reproducing a phenotype reminiscent of bronchopulmonary dysplasia (BPD). Neither intratracheal surfactant nor saline affected the survival or the hyperoxia-induced BPD phenotype of the pups. Using PET-CT, we demonstrate that 82.5% of the injected radioactive tracer goes and remains in the lungs, with a decrease of only 4% after 150 min. Surfactant and saline can safely and effectively be administered in spontaneously breathing preterm rabbits. The described model and method enable researchers to evaluate intratracheal pharmacological interventions for the treatment of BPD. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
40. Quenching of tryptophan fluorescence in a highly scattering solution: Insights on protein localization in a lung surfactant formulation.
- Author
-
Ronda, Luca, Pioselli, Barbara, Catinella, Silvia, Salomone, Fabrizio, Marchetti, Marialaura, and Bettati, Stefano
- Subjects
QUENCHING (Chemistry) ,TRYPTOPHAN ,PULMONARY surfactant ,RESPIRATORY distress syndrome ,LUMINESCENCE - Abstract
CHF5633 (Chiesi Farmaceutici, Italy) is a synthetic surfactant developed for respiratory distress syndrome replacement therapy in pre-term newborn infants. CHF5633 contains two phospholipids (dipalmitoylphosphatidylcholine and 1-palmitoyl-2oleoyl-sn-glycero-3-phosphoglycerol sodium salt), and peptide analogues of surfactant protein C (SP-C analogue) and surfactant protein B (SP-B analogue). Both proteins are fundamental for an optimal surfactant activity in vivo and SP-B genetic deficiency causes lethal respiratory failure after birth. Fluorescence emission of the only tryptophan residue present in SP-B analogue (SP-C analogue has none) could in principle be exploited to probe SP-B analogue conformation, localization and interaction with other components of the pharmaceutical formulation. However, the high light scattering activity of the multi-lamellar vesicles suspension characterizing the pharmaceutical surfactant formulation represents a challenge for such studies. We show here that quenching of tryptophan fluorescence and Singular Value Decomposition analysis can be used to accurately calculate and subtract background scattering. The results indicate, with respect to Trp microenvironment, a conformationally homogeneous population of SP-B. Trp is highly accessible to the water phase, suggesting a surficial localization on the membrane of phospholipid vesicles, similarly to what observed for full length SP-B in natural lung surfactant, and supporting an analogous role in protein anchoring to the lipid phase. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
41. Effects of budesonide and surfactant in preterm fetal sheep.
- Author
-
Kothe, T. Brett, Royse, Emily, Kemp, Matthew W., Schmidt, Augusto, Salomone, Fabrizio, Saito, Masatoshi, Usuda, Haruo, Watanabe, Shimpei, Musk, Gabrielle C., Jobe, Alan H., and Hillman, Noah H.
- Subjects
ARTIFICIAL respiration ,BUDESONIDE ,SURFACE active agents - Abstract
Mechanical ventilation causes lung injury and systemic inflammatory responses in preterm sheep and is associated with bronchopulmonary dysplasia (BPD) in preterm infants. Budesonide added to surfactant decreased BPD by 20% in infants. We wanted to determine the effects of budesonide and surfactant on injury from high tidal volume (V
T ) ventilation in preterm lambs. Ewes at 125 Δ 1 days gestational age had fetal surgery to expose fetal head and chest with placental circulation intact. Lambs were randomized to 1) mechanical ventilation with escalating VT to target 15 ml/kg by 15 min or 2) continuous positive airway pressure (CPAP) of 5 cmH2 O. After the 15-min intervention, lambs were given surfactant 100 mg/kg with saline, budesonide 0.25 mg/kg, or budesonide 1 mg/kg. The fetuses were returned to the uterus for 24 h and then delivered and ventilated for 30 min to assess lung function. Budesonide levels were low in lung and plasma. CPAP groups had improved oxygenation, ventilation, and decreased injury markers compared with fetal VT lambs. Budesonide improved ventilation in CPAP lambs. Budesonide decreased lung weights and lung liquid and increased lung compliance and surfactant protein mRNA. Budesonide decreased proinflammatory and acutephase responses in lung. Airway thickness increased in animals not receiving budesonide. Systemically, budesonide decreased monocyte chemoattractant protein-1 mRNA and preserved glycogen in liver. Results with 0.25 and 1 mg/kg budesonide were similar. We concluded that budesonide with surfactant matured the preterm lung and decreased the liver responses but did not improve lung function after high VT injury in fetal sheep. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
42. Surfactant replacement therapy in combination with different non-invasive ventilation techniques in spontaneously-breathing, surfactant-depleted adult rabbits.
- Author
-
Ricci, Francesca, Casiraghi, Costanza, Storti, Matteo, D’Alò, Francesco, Catozzi, Chiara, Ciccimarra, Roberta, Ravanetti, Francesca, Cacchioli, Antonio, Villetti, Gino, Civelli, Maurizio, Murgia, Xabi, Carnielli, Virgilio, and Salomone, Fabrizio
- Subjects
NONINVASIVE ventilation ,RESPIRATORY distress syndrome treatment ,SURFACE active agents ,LUNG physiology ,AUTOPSY - Abstract
Nasal intermittent positive pressure ventilation (NIPPV) holds great potential as a primary ventilation support method for Respiratory Distress Syndrome (RDS). The use of NIPPV may also be of great value combined with minimally invasive surfactant delivery. Our aim was to implement an in vivo model of RDS, which can be managed with different non-invasive ventilation (NIV) strategies, including non-synchronized NIPPV, synchronized NIPPV (SNIPPV), and nasal continuous positive airway pressure (NCPAP). Forty-two surfactant-depleted adult rabbits were allocated in six different groups: three groups of animals were treated with only NIV for three hours (NIPPV, SNIPPV, and NCPAP groups), while three other groups were treated with surfactant (SF) followed by NIV (NIPPV+SF, SNIPPV+SF, and NCPAP+SF groups). Arterial gas exchange, ventilation indices, and dynamic compliance were assessed. Post-mortem the lungs were sampled for histological evaluation. Surfactant depletion was successfully achieved by repeated broncho-alveolar lavages (BALs). After BALs, all animals developed a moderate respiratory distress, which could not be reverted by merely applying NIV. Conversely, surfactant administration followed by NIV induced a rapid improvement of arterial oxygenation in all surfactant-treated groups. Breath synchronization was associated with a significantly better response in terms of gas exchange and dynamic compliance compared to non-synchronized NIPPV, showing also the lowest injury scores after histological assessment. The proposed in vivo model of surfactant deficiency was successfully managed with NCPAP, NIPPV, or SNIPPV; this model resembles a moderate respiratory distress and it is suitable for the preclinical testing of less invasive surfactant administration techniques. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
43. Estimating the contribution of surfactant replacement therapy to the alveolar pool: An in vivo study based on 13C natural abundance in rabbits.
- Author
-
Giambelluca, Sonia, Ricci, Francesca, Simonato, Manuela, Correani, Alessio, Casiraghi, Costanza, Storti, Matteo, Cogo, Paola, Salomone, Fabrizio, and Carnielli, Virgilio Paolo
- Subjects
SURFACE active agents ,LABORATORY rabbits ,CHEMICAL kinetics ,PHARMACEUTICAL chemistry ,PHOSPHOLIPIDS - Abstract
Variation of the isotopic abundance of selected nutrients and molecules has been used for pharmacological and kinetics studies under the premise that the administered molecule has a different isotopic enrichment from the isotopic background of the recipient subject. The aim of this study is to test the feasibility of assessing the contribution of exogenous surfactant phospholipids to the endogenous alveolar pool in vivo after exogenous surfactant replacement therapy in rabbits. The study consisted in measuring the consistency of
13 C/12 C ratio of disaturatedphosphatidylcholine palmitate (DSPC-PA) in 7 lots of poractant alfa, produced over a year, and among bronchoalveolar lavages of 20 rabbits fed with a standard chow. A pilot study was performed in a rabbit model of lavage-induced surfactant deficiency: 7 control rabbits and 4 treated with exogenous surfactant. The contribution of exogenous surfactant to the alveolar pool was assessed after intra-tracheal administration of 200 mg/kg of poractant alfa. The13 C content of DSPC-PA was measured by isotope ratio mass spectrometry. The mean DSPC-PA13 C/12 C ratio of the 7 lots of poractant alfa was -18.8‰ with a SD of 0.1‰ (range: -18.9‰; -18.6‰). The mean13 C/12 C ratio of surfactant DSPC recovered from the lung lavage of 20 rabbits was -28.8 ± 1.2‰ (range: -31.7‰; -25.7‰). The contribution of exogenous surfactant to the total alveolar surfactant could be calculated in the treated rabbits, and it ranged from 83.9% to 89.6%. This pilot study describes a novel method to measure the contribution of the exogenous surfactant to the alveolar pool. This method is based on the natural variation of13 C, and therefore it does not require the use of chemically synthetized tracers. This method could be useful in human research and especially in surfactant replacement studies in preterm infants. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
44. Efficient Interfacially Driven Vehiculization of Corticosteroids by Pulmonary Surfactant.
- Author
-
Hidalgo, Alberto, Salomone, Fabrizio, Fresno, Nieves, Orellana, Guillermo, Cruz, Antonio, and Perez-Gil, Jesus
- Subjects
- *
BUDESONIDE , *STEROID drugs , *PULMONARY surfactant , *BIOSURFACTANTS , *BECLOMETHASONE dipropionate - Abstract
Pulmonary surfactant is a crucial system to stabilize the respiratory air-liquid interface. Furthermore, pulmonary surfactant has been proposed as an effective method for targeting drugs to the lungs. However, few studies have examined in detail the mechanisms of incorporation of drugs into surfactant, the impact of the presence of drugs on pulmonary surfactant performance at the interface under physiologically meaningful conditions, or the ability of pulmonary surfactant to use the air-liquid interface to vehiculise drugs to long distances. This study focuses on the ability of pulmonary surfactant to interfacially vehiculize corticosteroids such as beclomethasone dipropionate (BDP) or Budesonide (BUD) as model drugs. The main objectives have been to (a) characterize the incorporation of corticosteroids into natural and synthetic surfactants, (b) evaluate whether the presence of corticosteroids affects surfactant functionality, and (c) determine whether surfactant preparations enable the efficient spreading and distribution of BDP and BUD along the air-liquid interface. We have compared the performance of a purified surfactant from porcine lungs and two clinical surfactants: Poractant alfa, a natural surfactant of animal origin extensively used to treat premature babies, and CHF5633, a new synthetic surfactant preparation currently under clinical trials. Both, natural and clinical surfactants spontaneously incorporated corticosteroids up to at least 10% by mass with respect to phospholipid content. The presence of the drugs did not interfere with their ability to efficiently adsorb into air-liquid interfaces and form surface active films able to reach and sustain very low surface tensions (<2 mN/m) under compression-expansion cycling mimicking breathing dynamics. Furthermore, the combination of clinical surfactant with corticosteroids efficiently promoted the active diffusion of the drug to long distances along the air-liquid interface. This effect could not be mimicked by vehiculisation of corticosteroids in liposomes or in micellar emulsions similar to the formulations currently in use to deliver anti-inflammatory corticosteroids through inhalation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
45. Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs.
- Author
-
Rey-Santano, Carmen, Mielgo, Victoria E., Murgia, Xabier, Gomez-Solaetxe, Miguel Angel, Salomone, Fabrizio, Bianco, Federico, Pelizzi, Nicola, Loureiro, Begoña, and López de Heredia y Goya, Jon
- Published
- 2017
- Full Text
- View/download PDF
46. Physiological, Biochemical, and Biophysical Characterization of the Lung-Lavaged Spontaneously-Breathing Rabbit as a Model for Respiratory Distress Syndrome.
- Author
-
Ricci, Francesca, Catozzi, Chiara, Murgia, Xabier, Rosa, Brenda, Amidani, Davide, Lorenzini, Luca, Bianco, Federico, Rivetti, Claudio, Catinella, Silvia, Villetti, Gino, Civelli, Maurizio, Pioselli, Barbara, Dani, Carlo, and Salomone, Fabrizio
- Subjects
RESPIRATORY distress syndrome treatment ,BIOPHYSICS ,IRRIGATION (Medicine) ,AIRWAY (Anatomy) ,PREMATURE labor ,LUNG physiology ,LABORATORY rabbits - Abstract
Nasal continuous positive airway pressure (nCPAP) is a widely accepted technique of non-invasive respiratory support in spontaneously-breathing premature infants with respiratory distress syndrome (RDS). Surfactant administration techniques compatible with nCPAP ventilation strategy are actively investigated. Our aim is to set up and validate a respiratory distress animal model that can be managed on nCPAP suitable for surfactant administration techniques studies. Surfactant depletion was induced by bronchoalveolar lavages (BALs) on 18 adult rabbits. Full depletion was assessed by surfactant component analysis on the BALs samples. Animals were randomized into two groups: Control group (nCPAP only) and InSurE group, consisting of a bolus of surfactant (Poractant alfa, 200 mg/kg) followed by nCPAP. Arterial blood gases were monitored until animal sacrifice, 3 hours post treatment. Lung mechanics were evaluated just before and after BALs, at the time of treatment, and at the end of the procedure. Surfactant phospholipids and protein analysis as well as surface tension measurements on sequential BALs confirmed the efficacy of the surfactant depletion procedure. The InSurE group showed a significant improvement of blood oxygenation and lung mechanics. On the contrary, no signs of recovery were appreciated in animals treated with just nCPAP. The surfactant-depleted adult rabbit RDS model proved to be a valuable and efficient preclinical tool for mimicking the clinical scenario of preterm infants affected by mild/moderate RDS who spontaneously breathe and do not require mechanical ventilation. This population is of particular interest as potential target for the non-invasive administration of surfactant. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
47. Role of cholesterol on the transfection barriers of cationic lipid/DNA complexes.
- Author
-
Pozzi, Daniela, Cardarelli, Francesco, Salomone, Fabrizio, Marchini, Cristina, Amenitsch, Heinz, Barbera, Giorgia La, and Caracciolo, Giulio
- Subjects
CHOLESTEROL ,CATIONS ,LIPOSOMES ,X-ray scattering ,ENDOCYTOSIS - Abstract
Most lipid formulations need cholesterol for efficient transfection, but the precise motivation remains unclear. Here, we have investigated the effect of cholesterol on the transfection efficiency (TE) of cationic liposomes made of 1,2-dioleoyl-3-trimethylammonium-propane and dioleoylphosphocholine in Chinese hamster ovary cells. The transfection mechanisms of cholesterol-containing lipoplexes have been investigated by TE, synchrotron small angle X-ray scattering, and laser scanning confocal microscopy experiments. We prove that cholesterol-containing lipoplexes enter the cells using different endocytosis pathways. Formulations with high cholesterol content efficiently escape from endosomes and exhibit a lamellar-nonlamellar phase transition in mixture with biomembrane mimicking lipid formulations. This might explain both the DNA release ability and the high transfection efficiency. These studies highlight the enrichment in cholesterol as a decisive factor for transfection and will contribute to the rational design of lipid nanocarriers with superior TE. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
48. Mechanistic Insight into CM18-Tat11 Peptide Membrane-Perturbing Action by Whole-Cell Patch-Clamp Recording.
- Author
-
Fasoli, Anna, Salomone, Fabrizio, Benedusi, Mascia, Boccardi, Claudia, Rispoli, Giorgio, Beltram, Fabio, and Cardarelli, Francesco
- Subjects
- *
PEPTIDE analysis , *CELL-penetrating peptides , *PEPTIDE antibiotics , *ELECTROSTATICS , *CHIMERISM - Abstract
The membrane-destabilization properties of the recently-introduced endosomolytic CM18-Tat11 hybrid peptide (KWKLFKKIGAVLKVLTTG-YGRKKRRQRRR, residues 1-7 of cecropin-A, 2-12 of melittin, and 47-57 of HIV-1 Tat protein) are investigated in CHO-K1 cells by using the whole-cell configuration of the patch-clamp technique. CM18-Tat11, CM18, and Tat11 peptides are administered to the cell membrane with a computer-controlled micro-perfusion system. CM18-Tat11 induces irreversible cell-membrane permeabilization at concentrations (⩾4 μM) at which CM18 triggers transient pore formation, and Tat11 does not affect membrane integrity. We argue that the addition of the Tat11 module to CM18 is able to trigger a shift in the mechanism of membrane destabilization from "toroidal" to "carpet", promoting a detergent-like membrane disruption. Collectively, these results rationalize previous observations on CM18-Tat11 delivery properties that we believe can guide the engineering of new modular peptides tailored to specific cargo-delivery applications. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
49. Enhanced Bioactivity ofInternally FunctionalizedCationic Dendrimers with PEG Cores.
- Author
-
Albertazzi, Lorenzo, Mickler, Frauke M., Pavan, GiovanniM., Salomone, Fabrizio, Bardi, Giuseppe, Panniello, Mariangela, Amir, Elizabeth, Kang, Taegon, Killops, Kato L., Bräuchle, Christoph, Amir, Roey J., and Hawker, Craig J.
- Published
- 2012
- Full Text
- View/download PDF
50. Lung Deposition of Surfactant Delivered via a Dedicated Laryngeal Mask Airway in Piglets.
- Author
-
Nord, Anders, Cunha-Goncalves, Doris, Linnér, Rikard, Bianco, Federico, Salomone, Fabrizio, Ricci, Francesca, Lombardini, Marta, Micaglio, Massimo, Trevisanuto, Daniele, and Perez-de-Sa, Valeria
- Subjects
LARYNGEAL masks ,PULMONARY surfactant ,LUNGS ,CONTINUOUS positive airway pressure ,VOCAL cords ,PIGLETS - Abstract
It is unknown if the lung deposition of surfactant administered via a catheter placed through a laryngeal mask airway (LMA) is equivalent to that obtained by bolus instillation through an endotracheal tube. We compare the lung deposition of surfactant delivered via two types of LMA with the standard technique of endotracheal instillation. 25 newborn piglets on continuous positive airway pressure support (CPAP) were randomized into three groups: 1—LMA-camera (integrated camera and catheter channel; catheter tip below vocal cords), 2—LMA-standard (no camera, no channel; catheter tip above the glottis), 3—InSurE (Intubation, Surfactant administration, Extubation; catheter tip below end of endotracheal tube). All animals received 100 mg·kg
−1 of poractant alfa mixed with99m Technetium-nanocolloid. Surfactant deposition was measured by gamma scintigraphy as a percentage of the administered dose. The median (range) total lung surfactant deposition was 68% (10–85), 41% (5–88), and 88% (67–92) in LMA-camera, LMA-standard, and InSurE, respectively, which was higher (p < 0.05) in the latter. The deposition in the stomach and nasopharynx was higher with the LMA-standard. The surfactant deposition via an LMA was lower than that obtained with InSurE. Although not statistically significant, introducing the catheter below the vocal cords under visual control with an integrated camera improved surfactant LMA delivery by 65%. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.